Pharma major Laurus Labs has generated investor wealth of more than Rs 40,000 crore in nearly a year, emerging as a multibagger with gains of 120% from its 52-week low. The company’s market capitalisation climbed to Rs 71,763 crore on the NSE from Rs 31,555 crore on May 22, 2025 - the day the stock touched its one-year low of Rs 584.50. Despite the sharp rally, analysts believe the stock could still offer further upside, though they advise investors to maintain strict stop losses given the steep run-up.
The Hyderabad-based pharmaceuticals and biotechnology company hit a fresh 52-week high of Rs 1,333.50 on Monday, extending its super run on the D-Street. Its shares are trading above their 50-day and 200-day simple moving averages (SMAs) of Rs 1,096 and Rs 993, respectively according to Trendlyne data.
